{"A": {"Ticker": "A", "Company": "Agilent Technologies", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$165"}, {"Date": "2022-07-20", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$139"}, {"Date": "2022-07-08", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$175 to $140"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["UBS", "Credit Suisse", "Citigroup"], "Price_Target": 148.0}, "BIO": {"Ticker": "BIO", "Company": "Bio-Rad Laboratories", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$715"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Credit Suisse"], "Price_Target": 715.0}, "TECH": {"Ticker": "TECH", "Company": "Bio-Techne", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$465"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Credit Suisse"], "Price_Target": 465.0}, "CRL": {"Ticker": "CRL", "Company": "Charles River Laboratories", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$285"}, {"Date": "2022-08-04", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$350 to $250"}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Morgan Stanley", "Credit Suisse"], "Price_Target": 267.5}, "DHR": {"Ticker": "DHR", "Company": "Danaher Corporation", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$340"}, {"Date": "2022-08-17", "Rating": "Resumed", "Organization": "Bernstein", "Rating_Change": "Outperform", "Target_Change": "$330 to $340"}, {"Date": "2022-07-20", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$297"}, {"Date": "2022-06-01", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$299 to $310"}], "Score": 1.75, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "A", "Analists": ["UBS", "RBC Capital Mkts", "Credit Suisse", "Bernstein"], "Price_Target": 321.75}, "ILMN": {"Ticker": "ILMN", "Company": "Illumina", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$230"}, {"Date": "2022-07-13", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$350 to $150"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Barclays", "Credit Suisse"], "Price_Target": 190.0}, "IQV": {"Ticker": "IQV", "Company": "IQVIA", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$300"}, {"Date": "2022-07-15", "Rating": "Initiated", "Organization": "SVB Leerink", "Rating_Change": "Outperform", "Target_Change": "$256"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["SVB Leerink", "Credit Suisse"], "Price_Target": 278.0}, "LEN": {"Ticker": "LEN", "Company": "Lennar", "Sector": "Consumer Discretionary", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$82"}, {"Date": "2022-08-12", "Rating": "Downgrade", "Organization": "Wedbush", "Rating_Change": "Outperform to Neutral", "Target_Change": ""}, {"Date": "2022-07-12", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$83 to $80"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "E", "Analists": ["BofA Securities", "JP Morgan", "Wedbush"], "Price_Target": 81.0}, "PKI": {"Ticker": "PKI", "Company": "PerkinElmer", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$175"}, {"Date": "2022-08-18", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$190 to $170"}, {"Date": "2022-08-02", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$178"}, {"Date": "2022-07-20", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$160"}, {"Date": "2022-07-05", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$150"}], "Score": -0.4, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Evercore ISI", "Stifel", "BofA Securities", "UBS", "Credit Suisse"], "Price_Target": 166.6}, "TMO": {"Ticker": "TMO", "Company": "Thermo Fisher Scientific", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$675"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Credit Suisse"], "Price_Target": 675.0}, "WAT": {"Ticker": "WAT", "Company": "Waters Corporation", "Sector": "Health Care", "Updated": "2022-08-25", "Rating": [{"Date": "2022-08-25", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$345"}, {"Date": "2022-07-20", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$349"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Credit Suisse"], "Price_Target": 347.0}}